News

October 12, 2017

Genentech/Roche Releases Clinical Trial Update for SUNFISH (RG7916)

Genentech/Roche Releases Clinical Trial Update for SUNFISH (RG7916)

Genentech/Roche has provided the below community statement with clinical trial updates for SUNFISH (Type 2/3). The first patient is now enrolled in SUNFISH, as the trial advances to part two, which is designed to be a pivotal marketing registration trial. 

Dear SMA...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

September 28, 2017

Cure SMA Contributes Article to a Special Issue of the Journal Gene Therapy

To celebrate the FDA approval of Spinraza, Cure SMA contributed an article to the September special issue of the journal Gene Therapy. The issue , “Spinraza and Advanced Therapies: a stakeholder special,” covers a variety of perspectives and includes comments and review papers from SMA research funders, people affected by SMA,...

READ MORE   |  

Topics: Our Impact, Research, Front Page News

September 19, 2017

Novartis Releases Update on LMI070 (Branaplam) Clinical Trial

Novartis Releases Update on LMI070 (Branaplam) Clinical Trial

Novartis has released the following update for the LMI070 (branaplam) clinical trial, on behalf of the program team. 

Dear SMA community,

For years, our researchers have been working hard to develop a new treatment for SMA. One promising compound in our neuroscience...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

Items 1 - 3 of 160  12345678910Next

© 2014 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software